7 days Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of “Hold” by BrokeragesMarketBeat
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus recommendation of “Hold” by the ten analysts that are covering the firm, MarketBeat reports. Seven analysts have rated the stock with a hold rating an…
Compound (COMP) · Nasdaq 100 · Pharmaceuticals
X